Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. [electronic resource]
- International journal of radiation oncology, biology, physics 07 2018
- 558-563 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1879-355X
10.1016/j.ijrobp.2018.02.022 doi
Aged Aged, 80 and over Carcinoma, Non-Small-Cell Lung--pathology Feasibility Studies Female Humans Lung Neoplasms--pathology Male Middle Aged Neoplasm Staging Proton Therapy Radiosurgery Risk